BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17630560)

  • 1. Tumor markers and treatments for Kaposi sarcoma.
    Anderson LA; Goedert JJ
    AIDS; 2007 Jul; 21(12):1637-9. PubMed ID: 17630560
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diagnostic image (335). A man with tumours in the oral cavity].
    Hartgerink-Lutgens I; Kremer B
    Ned Tijdschr Geneeskd; 2007 Aug; 151(31):1729. PubMed ID: 17784695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma during potent antiretroviral therapy.
    Connick E; Kane MA; White IE; Ryder J; Campbell TB
    Clin Infect Dis; 2004 Dec; 39(12):1852-5. PubMed ID: 15578411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kaposi's sarcoma-associated immune reconstitution following highly active antiretroviral treatment initiation.
    Chan DJ
    Int J STD AIDS; 2006 Jan; 17(1):72. PubMed ID: 16409689
    [No Abstract]   [Full Text] [Related]  

  • 5. Kaposi sarcoma flares during effective antiretroviral treatment.
    Aboulafia DM
    AIDS Read; 2005 Apr; 15(4):190-1. PubMed ID: 15844240
    [No Abstract]   [Full Text] [Related]  

  • 6. Timing of highly active antiretroviral therapy and chemotherapy for Kaposi's sarcoma in patients with HIV infection.
    Loke WC; Spittle MF; Mitchell S; Kulasegaram R
    Int J STD AIDS; 2006 Aug; 17(8):565-6. PubMed ID: 16925908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era.
    El Amari EB; Toutous-Trellu L; Gayet-Ageron A; Baumann M; Cathomas G; Steffen I; Erb P; Mueller NJ; Furrer H; Cavassini M; Vernazza P; Hirsch HH; Bernasconi E; Hirschel B;
    AIDS; 2008 May; 22(9):1019-28. PubMed ID: 18520345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AIDS-associated Kaposi's sarcoma associated with a low viral load and a high CD4 cell count.
    Stebbing J; Powles T; Bower M
    AIDS; 2008 Feb; 22(4):551-2. PubMed ID: 18301078
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical and pathological features of Kaposi sarcoma herpesvirus-associated inflammatory cytokine syndrome.
    Piñeiro F; Climent F; Imaz A; Gudiol C; Niubó J; Palomar-Muñoz A; Serrano T; Saumoy M; Podzamczer D
    AIDS; 2020 Nov; 34(14):2097-2101. PubMed ID: 32796215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Confirming shedding of human herpesvirus 8 in urine from infected patients in Brazil.
    Santos-Fortuna E; Caterino-de-Araujo A
    J Clin Microbiol; 2005 Feb; 43(2):1008. PubMed ID: 15695733
    [No Abstract]   [Full Text] [Related]  

  • 11. Editorial commentary: treatment of Kaposi sarcoma in the highly active antiretroviral therapy era.
    Dupin N; Del Giudice P
    Clin Infect Dis; 2008 Aug; 47(3):418-20. PubMed ID: 18582204
    [No Abstract]   [Full Text] [Related]  

  • 12. Resolution of conjunctival Kaposi sarcoma after institution of highly active antiretroviral therapy alone.
    Leder HA; Galor A; Peters GB; Kedhar SR; Dunn JP; Thorne JE
    Br J Ophthalmol; 2008 Jan; 92(1):151. PubMed ID: 18156387
    [No Abstract]   [Full Text] [Related]  

  • 13. Nearly identical strains of human herpesvirus 8 in couples discordant for Kaposi's sarcoma.
    Kouri V; Marini A; Nambiar S; Rodriguez ME; Capo V; Resik S; Mantecon B; Martinez A; Köhler-Hansner KJ; Hengge UR
    AIDS; 2007 Mar; 21(6):765-8. PubMed ID: 17413700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First report of Kaposi's sarcoma-associated herpesvirus DNA sequences from Cuban Kaposi's sarcoma patients without HIV infection.
    Kourí V; Martínez PA; Acosta B; Rodríguez ME; Blanco O; Capó V; González RL; Viera J; Hengge UR
    AIDS; 2007 Oct; 21(15):2113-5. PubMed ID: 17885307
    [No Abstract]   [Full Text] [Related]  

  • 15. Absence of human herpesvirus 8 sequences in prostate specimens.
    Lebbé C; Pellet C; Tatoud R; Agbalika F; Dosquet P; Desgrez JP; Morel P; Calvo F
    AIDS; 1997 Feb; 11(2):270. PubMed ID: 9030389
    [No Abstract]   [Full Text] [Related]  

  • 16. Fatal Kaposi's sarcoma-associated immune reconstitution following highly active antiretroviral therapy.
    Kawsar M
    Int J STD AIDS; 2005 Aug; 16(8):582-3; author reply 583. PubMed ID: 16105195
    [No Abstract]   [Full Text] [Related]  

  • 17. Kaposi sarcoma and its changing course in HIV infection.
    Ball SC
    AIDS Read; 2003 Oct; 13(10):470, 475-6, 479. PubMed ID: 14596224
    [No Abstract]   [Full Text] [Related]  

  • 18. The effects of human herpesvirus 8 infection and interferon-gamma response in cutaneous lesions of Kaposi sarcoma differ among human immunodeficiency virus-infected and uninfected individuals.
    Guedes F; de Andrade HF; Fernandes ER; Tuon FF; Brasil RA; Pagliari C; Duarte MI
    Br J Dermatol; 2008 Sep; 159(4):839-46. PubMed ID: 18644020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HHV-8 linked to Kaposi's sarcoma, Castleman's disease and primary effusion lymphoma in a HIV-1-infected man.
    Bestawros A; Boulassel MR; Michel RP; Routy JP
    J Clin Virol; 2008 Jun; 42(2):179-81. PubMed ID: 18343194
    [No Abstract]   [Full Text] [Related]  

  • 20. HIV-associated oral Kaposi sarcoma and HHV-8: a review.
    Feller L; Lemmer J; Wood NH; Jadwat Y; Raubenheimer EJ
    J Int Acad Periodontol; 2007 Oct; 9(4):129-36. PubMed ID: 17987883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.